Business Description
Xvivo Perfusion AB
NAICS : 334517
SIC : 3842
ISIN : SE0004840718
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.31 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.17 | |||||
Interest Coverage | 74.23 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 46.8 | |||||
Beneish M-Score | -1.85 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 44.8 | |||||
3-Year FCF Growth Rate | -5.1 | |||||
3-Year Book Growth Rate | 20.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 46.29 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 37.66 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 84.91 | |||||
9-Day RSI | 63.85 | |||||
14-Day RSI | 50.27 | |||||
3-1 Month Momentum % | -11.95 | |||||
6-1 Month Momentum % | -1.78 | |||||
12-1 Month Momentum % | 84.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.49 | |||||
Quick Ratio | 4.23 | |||||
Cash Ratio | 2.98 | |||||
Days Inventory | 304.71 | |||||
Days Sales Outstanding | 74.33 | |||||
Days Payable | 68.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | 0.41 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.41 | |||||
Operating Margin % | 7.72 | |||||
Net Margin % | 27.21 | |||||
FCF Margin % | 8.98 | |||||
ROE % | 10.23 | |||||
ROA % | 9.09 | |||||
ROIC % | 3.19 | |||||
3-Year ROIIC % | 4.75 | |||||
ROC (Joel Greenblatt) % | 55.15 | |||||
ROCE % | 7.12 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 71.58 | |||||
Forward PE Ratio | 79.15 | |||||
PE Ratio without NRI | 71.58 | |||||
Shiller PE Ratio | 581.12 | |||||
PS Ratio | 19.6 | |||||
PB Ratio | 7.12 | |||||
Price-to-Tangible-Book | 18.57 | |||||
Price-to-Free-Cash-Flow | 217.95 | |||||
Price-to-Operating-Cash-Flow | 217.95 | |||||
EV-to-EBIT | 97.18 | |||||
EV-to-Forward-EBIT | 88.41 | |||||
EV-to-EBITDA | 97.18 | |||||
EV-to-Forward-EBITDA | 60.55 | |||||
EV-to-Revenue | 19.2 | |||||
EV-to-Forward-Revenue | 14 | |||||
EV-to-FCF | 214.02 | |||||
Price-to-GF-Value | 0.93 | |||||
Price-to-Projected-FCF | 7.55 | |||||
Price-to-Median-PS-Value | 1.12 | |||||
Price-to-Graham-Number | 7.69 | |||||
Price-to-Net-Current-Asset-Value | 23.44 | |||||
Price-to-Net-Cash | 57.97 | |||||
Earnings Yield (Greenblatt) % | 1.03 | |||||
FCF Yield % | 0.45 | |||||
Forward Rate of Return (Yacktman) % | 10.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:XVIPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Xvivo Perfusion AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 72.512 | ||
EPS (TTM) ($) | 0.639 | ||
Beta | 0.38 | ||
3-Year Sharpe Ratio | 0.37 | ||
3-Year Sortino Ratio | 0.67 | ||
Volatility % | 47.73 | ||
14-Day RSI | 50.27 | ||
14-Day ATR ($) | 0.18273 | ||
20-Day SMA ($) | 42.309 | ||
12-1 Month Momentum % | 84.21 | ||
52-Week Range ($) | 22.8 - 52.3768 | ||
Shares Outstanding (Mil) | 31.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Xvivo Perfusion AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Xvivo Perfusion AB Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Xvivo Perfusion AB Frequently Asked Questions
What is Xvivo Perfusion AB(XVIPF)'s stock price today?
When is next earnings date of Xvivo Perfusion AB(XVIPF)?
Does Xvivo Perfusion AB(XVIPF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |